XD and SF assisted with in vivo experiments. MC conceived of the study and finalized the manuscript. All authors read and approved the final manuscript.”
“Background Endometriosis is a gynaecological disease defined by the histological presence of endometrial glands and stroma outside the uterine cavity. Most commonly, endometrial

structures are implanted over visceral and peritoneal surfaces, but rarely also in the pericardium, pleura, and even brain [1]. The prevalence in the general female population is 6-10%; in women with pain, infertility or both, the frequency increases to 35-60% [2]. Endometriosis is usually GANT61 solubility dmso associated with infertility and pelvic pain such as chronic dysmenorrhea, intermestrual abdominal and pelvic pain, back pain, dysuria, dyschezia and dyspareunia [3]. Moreover, it is often associated with a decrease of ovarian reserve and reduction of ovarian find more volume [4]. Despite the fact that this disease is quite common

Sepantronium nmr among women, it is frequently misdiagnosed, the pathogenesis is unknown and the diagnostic and therapeutic protocols are still not fully adequate [1, 3]. Currently, none of the pathogenetic theories proposed, such as retrograde menstruation, coelomic metaplasia or staminal cells, has definitively been proved [1]. Interestingly, our research group has recently demonstrated the presence of endometrial implants outside the uterus in a significant number of female human fetuses, thus demonstrating that alterations in the fine-tuning of the primitive mullerian tube formation is one of the causes of endometriosis [5–9]. The anti-mullerian hormone (AMH) is a homodimeric glycoprotein member of the transforming many growth factor β (TGF-β) superfamily, which is secreted by Sertoli cells in the embryonic testes and is responsible of the regression of the mullerian duct [10].

In the female fetus ovarian granulosa cells begin to secrete low levels of AMH starting from the 32 week of gestation. Levels surge at the time of puberty to approximately 5-8 ng/mL but then gradually decline throughout reproductive life until they become undetectable by menopause. Therefore, AMH levels are considered good indicators of the ovarian reservoir [11]. Recent studies have demonstrated that AMH, as well as AMHRII (one of its receptors), are expressed in the adult female also in the endometrium, where, probably, act in a paracrine fashion and that negatively regulates cellular viability in the endometrium [12]. Leaving from this background, we decided to deeply investigate the potential role of AMH in regulating cell viability and proliferation of endometriosis cells, taking advantage of an in vitro model of epithelial and stromal endometriosis cells, recently generated in our laboratory [13].